Usefulness of endoscopic ultrasound-guided fine needle aspiration for splenic parenchyma in patients suspected of having primary splenic malignant lymphoma

 

 Permissions and Reprints

Abstract

Background and study aims The diagnosis of malignant lymphoma (ML) is sometimes difficult, especially in patients with primary splenic malignant lymphomas (psML) which have no lymph nodes capable of acting as the biopsy target. We carried out endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for “splenic parenchyma” in patients suspected of having a psML, even without any obvious neoplastic lesions in the spleen.

Patients and methods A retrospective study using medical records was conducted of eight patients suspected of having a psML that received EUS-FNA for the splenic parenchyma between January 2016 and January 2019. Data analyzed included clinical background, EUS-FNA procedure (puncture needle/route), diagnostic ability (pathological/flow cytometry [FCM]), and complications.

Results EUS-FNA was performed from the stomach in all eight cases, and no patients had complications. As a result of splenic parenchymal biopsy found on EUS-FNA, 75 % of patients (6/8) were histologically diagnosed with MLs, monoclonality of B-cells was identified in all cases (8/8) with FCM, and all patients (8/8) were definitively diagnosed with psMLs.

Conclusion EUS-FNA for “splenic parenchyma” is useful for patients with spML, even if they have no obvious neoplastic lesions in the spleen.

Publication History

Received: 02 June 2020

Accepted: 18 August 2020

Article published online:
01 January 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Alduaij W, Ivanov A, Honeychurch J. et al. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome mediated cell death in B-cell malignancies. Blood 2011; 117: 4519-4529
  CrossrefPubMedGoogle Scholar
• 2 Guputa TD, Coombes B, Brasfield RD. Primary malignant neoplasms of the spleen. Surg Gynecol Obstet 1965; 120: 647-960
  PubMedGoogle Scholar
• 3 Swerdlow SH, Campo E, Harris NL. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2017
  Google Scholar
• 4 Fujimoto K, Fujishiro M, Kato M. et al. Guidelines for gastroenterological in patients undergoing antithrombotic trearment. Dig Endosc 2014; 26: 1-14
  CrossrefPubMedGoogle Scholar
• 5 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
  CrossrefPubMedGoogle Scholar
• 6 Kehoe J, Straus DJ. Primary Lymphoma of the spleen. Surg Today 1992; 22: 371-375
  CrossrefPubMedGoogle Scholar
• 7 Ahmann DL, Keily JM, Harrison EG. et al. Malignant lymphoma of the spleen: A review of 49 cases in which the diagnosis was made at splenectomy. Cancer 1966; 19: 461-469
  CrossrefPubMedGoogle Scholar
• 8 Civardi G, Vallisa D, Bertʼe R. et al. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study. Am J Hematol 2001; 67: 93-99
  CrossrefPubMedGoogle Scholar
• 9 McInnes MDF, Kielar AZ, Macdonald DB. Percutaneous image-guided biopsy of the spleen: systematic review and meta-analysis of the complication rate and diagnostic accuracy. Radiology 2011; 260: 699-708
  CrossrefPubMedGoogle Scholar
• 10 Han B, Yang Z, Yang T. et al. Diagnostic splenectomy in patients with fever of unknown origin and splenomegaly. Acta Haematol 2008; 119: 83-88
  CrossrefPubMedGoogle Scholar
• 11 Vilmann P, Jacobson GK, Henriksen FW. et al. Endosonography guided with fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 1992; 38: 172-173
  CrossrefPubMedGoogle Scholar
• 12 Eloubeidi MA, Chen VK, Eltoum IA. et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003; 98: 2663-2668
  CrossrefPubMedGoogle Scholar
• 13 Fritscher-Ravens A, Mylonaki M, Pantes A. et al. Endoscopic ultrasound-guided biopsy for the diagnosis of focal lesions of the spleen. Am J Gastroenterol 2003; 98: 1022-1027
  CrossrefPubMedGoogle Scholar
• 14 Iwashita T, Yasuda I, Tsurumi H. et al. Endoscopic ultrasound-guided fine needle aspiration biopsy for splenic tumor: a case series. Endoscopy 2009; 41: 179-182
  Article in Thieme ConnectPubMedGoogle Scholar
• 15 Eloubeidi MA, Varadarajulu S, Eltoum IA. et al. Transgastric endoscopic ultrasound-guided fine-needle aspiration biopsy and flow cytometry of suspected lymphoma of the spleen. Endoscopy 2006; 38: 617-620
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Majzoub NE, Kharfan-Dabaja MA, Boulos FI. et al. Diagnosing diffuse large B-cell non-hodgkin lymphoma by endoscopic ultrasound-fine-needle aspiration of a splenic mass. J Clin Oncol 2013; 31: 223-225
  CrossrefPubMedGoogle Scholar
• 17 El Hajj II, Khalid A, Schoedel KE. et al. EUS-guided FNA diagnosis of primary splenic lymphoma. Gastrointest Endosc 2009; 69: 585-588
  CrossrefPubMedGoogle Scholar
• 18 Darr U, Khan Z, Khan MA. et al. Diagnosis of splenic lymphoma by endoscopic ultrasound guided fine needle aspiration: a case report and review of the literature. Case Rep Gastrointest Med 2017; 2017: 36-2910
  PubMedGoogle Scholar
• 19 Yasuda I, Turumi H, Omar S. et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy 2006; 38: 919-924
  Article in Thieme ConnectPubMedGoogle Scholar